Cargando…
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial
BACKGROUND: Finasteride, a 5-alpha reductase inhibitor may have effects on biomarkers such as prostate-specific antigen (PSA) that could be leveraged to improve screening. OBJECTIVE: To determine the predictive characteristics of biomarkers for prostate cancer for cancer on biopsy following 3 months...
Autores principales: | Hernandez, Javier, Gelfond, Jonathan, Goros, Martin, Liss, Michael A., Liang, Yuanyuan, Ankerst, Donna, Thompson, Ian M., Leach, Robin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177134/ https://www.ncbi.nlm.nih.gov/pubmed/30300367 http://dx.doi.org/10.1371/journal.pone.0204823 |
Ejemplares similares
-
Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials
por: Gelfond, Jonathan A., et al.
Publicado: (2022) -
A case control study of sarcosine as an early prostate cancer detection biomarker
por: Ankerst, Donna P., et al.
Publicado: (2015) -
Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
por: Chau, Cindy H., et al.
Publicado: (2015) -
Finasteride and male fertility
por: Gude, Dilip
Publicado: (2011) -
Post-finasteride syndrome()()
por: Pereira, Ana Francisca Junqueira Ribeiro, et al.
Publicado: (2020)